晚期胃肠道肿瘤患者肠道菌群紊乱及益生菌干预作用的临床研究
打开文本图片集
[摘要] 目的 探讨晚期胃肠道肿瘤患者肠道菌群紊乱及益生菌干预作用的临床效果。 方法 选择2015年6月~2016年6月期间收治的50例晚期胃肠道肿瘤患者作为研究组,分别在益生菌干预前后检测粪便中大肠杆菌、双歧杆菌、乳酸杆菌、肠球菌、酵母菌、葡萄球菌、消化链球菌数量,并与同期30例健康对照组作比较。 结果 益生菌干预前研究组双歧杆菌、乳酸杆菌及酵母菌数量明显少于对照组(P<0.05),大肠杆菌、葡萄球菌、肠球菌及消化链球菌数量明显多于对照组(P<0.05)。经益生菌干预后研究组双歧杆菌、乳酸杆菌及酵母菌数量明显较干预前增加(P<0.05),大肠杆菌、葡萄球菌、肠球菌及消化链球菌数量明显较干预前减少(P<0.05)。临床总有效率为92.0%。 结论 晚期胃肠道肿瘤患者伴有明显的肠道菌群紊乱,经益生菌干预能够有效纠正道菌群紊乱。
[关键词] 肠道菌群紊乱;益生菌;胃肠道肿瘤;微生态营养学
[中图分类号] R735.2 [文献标识码] A [文章编号] 1673-9701(2017)06-0016-03
[Abstract] Objective To research of intestinal flora disturbance and probiotics intervention in patients with advanced gastrointestinal cancer. Methods 50 cases patients with advanced gastrointestinal cancer from June 2015 to June 2016 were collected as research group, and escherichia coli, bacillus coli, lactic acid bacteria, lactic acid bacteria, yeast, staphylococcus and peptostreptococcus were detected before and after the intervention of probiotics, and were compared with 30 cases of healthy control group duringthe same period. Results Before probiotic intervention,the bacillus bifidus,lactic acid bacteria and yeast in the research group were significantly less than those in the control group(P<0.05), and escherichia colii, staphylococcus, streptococcus and peptostreptococcus were significantly more than those in the contro...
== 试读已结束,如需继续阅读敬请充值会员 ==
|
本站文章均为原创投稿,仅供下载参考,付费用户可查看完整且有格式内容!
(费用标准:38元/2月,98元/2年,微信支付秒开通!) |
升级为会员即可查阅全文 。如需要查阅全文,请 免费注册 或 登录会员 |